NVCR logo

NovoCure Limited (NVCR) Cash From Investing

Annual CFI:

-$140.24M-$324.39M(-176.16%)
December 31, 2024

Summary

  • As of today, NVCR annual cash from investing is -$140.24 million, with the most recent change of -$324.39 million (-176.16%) on December 31, 2024.
  • During the last 3 years, NVCR annual cash from investing has risen by +$4.59 million (+3.17%).
  • NVCR annual cash from investing is now -176.16% below its all-time high of $184.15 million, reached on December 31, 2023.

Performance

NVCR Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRcash flow metrics

Quarterly CFI:

$71.44M+$35.45M(+98.51%)
September 30, 2025

Summary

  • As of today, NVCR quarterly cash from investing is $71.44 million, with the most recent change of +$35.45 million (+98.51%) on September 30, 2025.
  • Over the past year, NVCR quarterly cash from investing has increased by +$61.24 million (+600.83%).
  • NVCR quarterly cash from investing is now -76.40% below its all-time high of $302.70 million, reached on September 30, 2021.

Performance

NVCR Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRcash flow metrics

TTM CFI:

$78.74M+$61.24M(+350.04%)
September 30, 2025

Summary

  • As of today, NVCR TTM cash from investing is $78.74 million, with the most recent change of +$61.24 million (+350.04%) on September 30, 2025.
  • Over the past year, NVCR TTM cash from investing has increased by +$98.27 million (+503.15%).
  • NVCR TTM cash from investing is now -77.38% below its all-time high of $348.08 million, reached on March 31, 2024.

Performance

NVCR TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

NVCR Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-176.2%+600.8%+503.1%
3Y3 Years+3.2%+147.6%+115.4%
5Y5 Years-171.4%-51.5%-16.3%

NVCR Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-176.2%+3.2%-71.0%+119.1%-77.4%+115.4%
5Y5-Year-176.2%+70.3%-76.4%+111.6%-77.4%+115.4%
All-TimeAll-Time-176.2%+70.3%-76.4%+111.6%-77.4%+115.4%

NVCR Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
$71.44M(+98.5%)
$78.74M(+350.0%)
Jun 2025
-
$35.99M(+656.0%)
$17.50M(+104.5%)
Mar 2025
-
-$6.47M(+70.9%)
-$392.93M(-180.2%)
Dec 2024
-$140.24M(-176.2%)
-$22.21M(-317.9%)
-$140.24M(-618.0%)
Sep 2024
-
$10.19M(+102.7%)
-$19.53M(-56.7%)
Jun 2024
-
-$374.44M(-252.1%)
-$12.47M(-103.6%)
Mar 2024
-
$246.22M(+150.0%)
$348.08M(+89.0%)
Dec 2023
$184.15M(+231.6%)
$98.50M(+470.7%)
$184.15M(+534.2%)
Sep 2023
-
$17.26M(+224.2%)
-$42.41M(+79.8%)
Jun 2023
-
-$13.90M(-116.9%)
-$209.91M(-421.4%)
Mar 2023
-
$82.29M(+164.3%)
-$40.26M(+71.2%)
Dec 2022
-$139.96M(+3.4%)
-$128.06M(+14.8%)
-$139.96M(+72.6%)
Sep 2022
-
-$150.24M(-196.5%)
-$510.99M(-780.4%)
Jun 2022
-
$155.76M(+994.6%)
-$58.04M(+73.2%)
Mar 2022
-
-$17.41M(+96.5%)
-$216.41M(-49.4%)
Dec 2021
-$144.83M(+69.4%)
-$499.09M(-264.9%)
-$144.83M(+44.2%)
Sep 2021
-
$302.70M(>+9900.0%)
-$259.38M(+37.5%)
Jun 2021
-
-$2.62M(-104.8%)
-$414.87M(+0.2%)
Mar 2021
-
$54.17M(+108.8%)
-$415.56M(+12.1%)
Dec 2020
-$472.85M(-815.2%)
-$613.64M(-516.8%)
-$472.85M(-602.8%)
Sep 2020
-
$147.22M(+4541.0%)
$94.03M(+269.9%)
Jun 2020
-
-$3.31M(-6.5%)
-$55.36M(-2.9%)
Mar 2020
-
-$3.11M(+93.3%)
-$53.79M(-4.1%)
DateAnnualQuarterlyTTM
Dec 2019
-$51.67M(-840.6%)
-$46.76M(-2050.7%)
-$51.67M(-671.1%)
Sep 2019
-
-$2.17M(-24.4%)
-$6.70M(-21.1%)
Jun 2019
-
-$1.75M(-76.7%)
-$5.53M(-19.6%)
Mar 2019
-
-$989.00K(+44.7%)
-$4.63M(+15.8%)
Dec 2018
-$5.49M(-163.7%)
-$1.79M(-78.0%)
-$5.49M(+2.8%)
Sep 2018
-
-$1.00M(-19.4%)
-$5.65M(+11.7%)
Jun 2018
-
-$842.00K(+54.7%)
-$6.40M(-31.3%)
Mar 2018
-
-$1.86M(+4.6%)
-$4.87M(-156.5%)
Dec 2017
$8.63M(-33.6%)
-$1.95M(-11.0%)
$8.63M(+20.2%)
Sep 2017
-
-$1.75M(-357.0%)
$7.18M(+59.9%)
Jun 2017
-
$682.00K(-94.1%)
$4.49M(+260.1%)
Mar 2017
-
$11.64M(+442.9%)
-$2.81M(-121.6%)
Dec 2016
$13.00M(+111.3%)
-$3.40M(+23.5%)
$12.99M(+111.9%)
Sep 2016
-
-$4.44M(+32.8%)
-$109.62M(-40.9%)
Jun 2016
-
-$6.61M(-124.1%)
-$77.78M(+28.7%)
Mar 2016
-
$27.45M(+121.8%)
-$109.11M(+5.3%)
Dec 2015
-$115.30M(-149.7%)
-$126.01M(-559.8%)
-$115.27M(-1173.0%)
Sep 2015
-
$27.41M(+172.2%)
$10.74M(+164.5%)
Jun 2015
-
-$37.95M(-278.3%)
-$16.66M(-26.0%)
Mar 2015
-
$21.28M(+161.7%)
-$13.22M(+80.8%)
Dec 2014
-$46.18M(-544.0%)
-
-
Jun 2014
-
-$34.50M(-0.0%)
-$69.00M(-100.0%)
Mar 2014
-
-$34.50M
-$34.50M
Dec 2013
$10.40M
-
-

FAQ

  • What is NovoCure Limited annual cash from investing?
  • What is the all-time high annual cash from investing for NovoCure Limited?
  • What is NovoCure Limited annual cash from investing year-on-year change?
  • What is NovoCure Limited quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for NovoCure Limited?
  • What is NovoCure Limited quarterly cash from investing year-on-year change?
  • What is NovoCure Limited TTM cash from investing?
  • What is the all-time high TTM cash from investing for NovoCure Limited?
  • What is NovoCure Limited TTM cash from investing year-on-year change?

What is NovoCure Limited annual cash from investing?

The current annual cash from investing of NVCR is -$140.24M

What is the all-time high annual cash from investing for NovoCure Limited?

NovoCure Limited all-time high annual cash from investing is $184.15M

What is NovoCure Limited annual cash from investing year-on-year change?

Over the past year, NVCR annual cash from investing has changed by -$324.39M (-176.16%)

What is NovoCure Limited quarterly cash from investing?

The current quarterly cash from investing of NVCR is $71.44M

What is the all-time high quarterly cash from investing for NovoCure Limited?

NovoCure Limited all-time high quarterly cash from investing is $302.70M

What is NovoCure Limited quarterly cash from investing year-on-year change?

Over the past year, NVCR quarterly cash from investing has changed by +$61.24M (+600.83%)

What is NovoCure Limited TTM cash from investing?

The current TTM cash from investing of NVCR is $78.74M

What is the all-time high TTM cash from investing for NovoCure Limited?

NovoCure Limited all-time high TTM cash from investing is $348.08M

What is NovoCure Limited TTM cash from investing year-on-year change?

Over the past year, NVCR TTM cash from investing has changed by +$98.27M (+503.15%)
On this page